Nagai et al. reported that the expression of hepatocyte growth factor promotes the progression of liver cancer through activating MAPK pathway, which further expressed transformational change and increased mesenchymal markers in Huh7 and HepG2 cells [31]. The gene discussed is HGF; the disease is liver cancer.